These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37847603)

  • 1. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation with Beta Major Thalassemia: The Association between the PRES Occurrence and Class of Beta Major Thalassemia.
    Jafari L; Behfar M; Tabatabaie S; Karamlou Y; Kashani H; Radmard AR; Mohseni R; Naji P; Ghanbari F; Ashkevari P; Fakhr H; Mohammadi S; Hamidieh AA
    Clin Transplant; 2024 Jan; 38(1):e15164. PubMed ID: 37847603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major.
    Li XY; Huang K; Zhou DH; Li Y; Xu HG; Weng WJ; Xu LH; Fang JP
    Clin Transplant; 2019 Jan; 33(1):e13459. PubMed ID: 30506735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes.
    Chen Q; Zhao X; Fu HX; Chen YH; Zhang YY; Wang JZ; Wang Y; Wang FR; Mo XD; Han W; Chen H; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
    Bone Marrow Transplant; 2020 Oct; 55(10):2035-2042. PubMed ID: 32305999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
    Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study.
    Behfar M; Babaei M; Radmard AR; Kooraki S; Farajifard H; Naji P; Taebi S; Hamidieh AA
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):e316-e321. PubMed ID: 32860910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
    Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents.
    Dandoy CE; Linscott LL; Davies SM; Leach JL; Myers KC; El-Bietar J; Chima RS; Pate A; Nelson A; Wallace G; Wong HR; Jodele S
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2028-32. PubMed ID: 26226408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRES in Pediatric HSCT: A Single-Center Experience.
    Kapoor R; Simalti A; Kumar R; Yanamandra U; Das S; Singh J; Nair V
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):433-437. PubMed ID: 29697577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients.
    Atça AÖ; Erok B; Aydoğdu S
    BMC Pediatr; 2021 Oct; 21(1):445. PubMed ID: 34629063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome.
    Zama D; Gasperini P; Berger M; Petris M; De Pasquale MD; Cesaro S; Guerzoni ME; Mastrodicasa E; Savina F; Ziino O; Kiren V; Muggeo P; Mura RM; Melchionda F; Zanazzo GA;
    Eur J Haematol; 2018 Jan; 100(1):75-82. PubMed ID: 29032616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of ruxolitinib in Graft-versus-Host disease prophylaxis for pediatric β-Thalassemia major patients after allogeneic stem cell transplantation: A retrospective cohort study.
    Hong X; Chen Y; Lu J; Lu Q
    Pediatr Transplant; 2023 Mar; 27(2):e14466. PubMed ID: 36597217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serum panel reactive antibodies on allogeneic hematopoietic stem cell transplantation in pediatric thalassemia patients: A single-center experience.
    Malbora B; Sarbay H; Dogusan Z; Atay AA
    Pediatr Transplant; 2024 Feb; 28(1):e14648. PubMed ID: 38063291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for hemorrhagic cystitis in children with β-thalassemia major after allogeneic hematopoietic stem cell transplantation].
    Chen XL; Luo XJ; Cao K; Huang T; Luo YG; Yang CL; Chen YS
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Oct; 25(10):1046-1051. PubMed ID: 37905762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Graft versus Host Disease in Beta Thalassemia Patients Following Allogeneic Haematopoietic Stem Cell Transplantation.
    Rafique N; Ali A; Ghaffor T; Khattak TA; Asghar MB; Chaudhry QU
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):480-483. PubMed ID: 38576294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ito Y; Toyama K; Honda A; Nakazaki K; Arai S; Kurokawa M
    J Infect Chemother; 2020 Feb; 26(2):265-268. PubMed ID: 31421950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major.
    Rostami T; Kasaeian A; Maleki N; Nikbakht M; Kiumarsi A; Tavangar SM; Taheri APH; Mousavi SA; Ghavamzadeh A
    Stem Cell Res Ther; 2021 Mar; 12(1):213. PubMed ID: 33781314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation.
    Cordelli DM; Masetti R; Bernardi B; Barcia G; Gentile V; Biagi C; Prete A; Pession A; Franzoni E
    Pediatr Blood Cancer; 2012 May; 58(5):785-90. PubMed ID: 21990274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.
    Chen S; Hu J; Xu L; Brandon D; Yu J; Zhang J
    Mol Neurobiol; 2016 Dec; 53(10):6897-6909. PubMed ID: 26666662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation.
    Hammerstrom AE; Howell J; Gulbis A; Rondon G; Champlin RE; Popat U
    Am J Hematol; 2013 Apr; 88(4):301-5. PubMed ID: 23460378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Outcomes of Critically Ill Pediatric Patients with Posterior Reversible Encephalopathy Syndrome.
    Fisler G; Monty MA; Kohn N; Assaad P; Trope R; Kessel A
    Neurocrit Care; 2020 Feb; 32(1):145-151. PubMed ID: 31069660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.